Loading clinical trials...
Loading clinical trials...
Randomized, Double-Blinded Clinical Trial to Evaluate the Incidence and Severity of Neuropsychiatric Side Effects and Antiviral Efficacy of Efavirenz Given as a Stepped Dosage Over 2 Weeks Versus the Usual Dosage in HIV-Infected Patients.
Conditions
Interventions
Efavirenz
Locations
10
Spain
Hospital Torrecardenas
Almería, Almeria, Spain
Hospital Universitario Puerta del Mar
Cadiz, Cadiz, Spain
Hospital de Jerez
Jerez de la Frontera, Cadiz, Spain
Hospital Universitario Reina Sofía
Córdoba, Cordoba, Spain
Hospital Juan Ramon Jimenez
Huelva, Huelva, Spain
Hospital Universitario Carlos Haya
Málaga, Malaga, Spain
Start Date
April 1, 2006
Primary Completion Date
January 1, 2008
Completion Date
January 1, 2008
Last Updated
January 15, 2009
NCT04929028
NCT06694805
NCT04142047
NCT07428330
NCT07225530
NCT06665646
Lead Sponsor
Sociedad Andaluza de Enfermedades Infecciosas
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions